Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 15 | 2024 | 106 | 4.360 |
Why?
|
| Calcium | 15 | 2018 | 480 | 2.610 |
Why?
|
| Peptide Fragments | 8 | 2024 | 308 | 2.460 |
Why?
|
| Presynaptic Terminals | 9 | 2014 | 53 | 2.360 |
Why?
|
| Neurons | 10 | 2021 | 1175 | 1.330 |
Why?
|
| Neuroprotective Agents | 4 | 2024 | 245 | 1.270 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 905 | 1.150 |
Why?
|
| Animals | 39 | 2023 | 15081 | 0.930 |
Why?
|
| Hippocampus | 7 | 2021 | 561 | 0.870 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 4 | 2011 | 7 | 0.850 |
Why?
|
| Mice | 22 | 2023 | 5913 | 0.780 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 103 | 0.750 |
Why?
|
| Homeostasis | 4 | 2020 | 188 | 0.730 |
Why?
|
| Nicotine | 8 | 2011 | 257 | 0.720 |
Why?
|
| Synaptosomes | 6 | 2011 | 21 | 0.700 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2018 | 59 | 0.660 |
Why?
|
| Drug Discovery | 1 | 2019 | 82 | 0.640 |
Why?
|
| Fear | 3 | 2017 | 249 | 0.610 |
Why?
|
| Molecular Probes | 1 | 2016 | 23 | 0.570 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2020 | 95 | 0.560 |
Why?
|
| Microglia | 3 | 2023 | 166 | 0.540 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 617 | 0.520 |
Why?
|
| Pharmaceutical Preparations | 1 | 2016 | 75 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 1609 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 169 | 0.500 |
Why?
|
| Calcium Channels | 2 | 2007 | 76 | 0.480 |
Why?
|
| Neostriatum | 2 | 2006 | 26 | 0.470 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2021 | 48 | 0.440 |
Why?
|
| Liver | 5 | 2021 | 479 | 0.430 |
Why?
|
| Synapses | 3 | 2019 | 180 | 0.400 |
Why?
|
| Purkinje Cells | 1 | 2011 | 20 | 0.400 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 5 | 0.400 |
Why?
|
| Cerebellum | 1 | 2011 | 73 | 0.400 |
Why?
|
| Amyloid | 1 | 2011 | 54 | 0.390 |
Why?
|
| Receptors, Serotonin | 2 | 2001 | 22 | 0.370 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 290 | 0.360 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 47 | 0.360 |
Why?
|
| Dopamine | 2 | 2011 | 245 | 0.350 |
Why?
|
| Schools, Medical | 3 | 2018 | 198 | 0.350 |
Why?
|
| Male | 23 | 2021 | 20025 | 0.350 |
Why?
|
| Models, Biological | 1 | 2013 | 677 | 0.340 |
Why?
|
| Receptors, Presynaptic | 2 | 2006 | 4 | 0.340 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 461 | 0.320 |
Why?
|
| Microscopy, Confocal | 5 | 2010 | 218 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 2231 | 0.320 |
Why?
|
| TRPC Cation Channels | 1 | 2007 | 7 | 0.310 |
Why?
|
| Corpus Striatum | 3 | 2009 | 104 | 0.310 |
Why?
|
| GTP-Binding Proteins | 2 | 2018 | 60 | 0.310 |
Why?
|
| Benzofurans | 3 | 2021 | 21 | 0.300 |
Why?
|
| Mice, Knockout | 6 | 2021 | 933 | 0.300 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 82 | 0.290 |
Why?
|
| Inflammation | 2 | 2023 | 618 | 0.290 |
Why?
|
| tau Proteins | 2 | 2020 | 167 | 0.290 |
Why?
|
| Neocortex | 2 | 2003 | 27 | 0.280 |
Why?
|
| Rats | 9 | 2011 | 3483 | 0.280 |
Why?
|
| Nicotinic Agonists | 4 | 2009 | 75 | 0.280 |
Why?
|
| Cell Line | 3 | 2020 | 1354 | 0.270 |
Why?
|
| Prefrontal Cortex | 1 | 2007 | 137 | 0.270 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 40 | 0.270 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2006 | 73 | 0.270 |
Why?
|
| Gossypium | 3 | 2021 | 5 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2019 | 1908 | 0.260 |
Why?
|
| Molecular Biology | 2 | 2015 | 46 | 0.240 |
Why?
|
| Humans | 13 | 2024 | 37093 | 0.240 |
Why?
|
| Luteolin | 2 | 2021 | 9 | 0.240 |
Why?
|
| Metabolomics | 4 | 2020 | 81 | 0.240 |
Why?
|
| Bungarotoxins | 4 | 2011 | 21 | 0.240 |
Why?
|
| Gliosis | 1 | 2023 | 24 | 0.230 |
Why?
|
| Neuroblastoma | 2 | 2001 | 129 | 0.220 |
Why?
|
| Bile Acids and Salts | 3 | 2018 | 33 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2009 | 1618 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 1371 | 0.210 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2018 | 9 | 0.200 |
Why?
|
| Oxidative Stress | 3 | 2017 | 938 | 0.200 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.200 |
Why?
|
| Plant Diseases | 2 | 2019 | 57 | 0.200 |
Why?
|
| Nematode Infections | 1 | 2021 | 1 | 0.200 |
Why?
|
| Tylenchoidea | 1 | 2021 | 3 | 0.200 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 146 | 0.200 |
Why?
|
| Synaptic Potentials | 1 | 2021 | 7 | 0.190 |
Why?
|
| Ceramides | 1 | 2021 | 42 | 0.190 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2000 | 5 | 0.190 |
Why?
|
| Nerve Endings | 1 | 2000 | 8 | 0.190 |
Why?
|
| Presenilin-1 | 1 | 2020 | 27 | 0.190 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 80 | 0.190 |
Why?
|
| Biguanides | 3 | 2009 | 7 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 220 | 0.180 |
Why?
|
| Axons | 1 | 2001 | 108 | 0.180 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 8 | 0.180 |
Why?
|
| Memory Disorders | 1 | 2020 | 73 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 122 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1015 | 0.180 |
Why?
|
| Mitochondria | 2 | 2017 | 487 | 0.170 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 893 | 0.170 |
Why?
|
| Fluorocarbons | 1 | 2020 | 26 | 0.170 |
Why?
|
| Xanthomonas | 1 | 2019 | 2 | 0.170 |
Why?
|
| Microbiological Techniques | 1 | 2019 | 11 | 0.170 |
Why?
|
| Fusarium | 1 | 2018 | 7 | 0.170 |
Why?
|
| Berberine | 1 | 2018 | 6 | 0.170 |
Why?
|
| Disease Management | 1 | 2019 | 61 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 97 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 448 | 0.160 |
Why?
|
| DNA Repair | 1 | 2020 | 188 | 0.160 |
Why?
|
| Nicotinic Antagonists | 3 | 2011 | 30 | 0.160 |
Why?
|
| Vitamin A Deficiency | 1 | 2017 | 13 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 122 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 77 | 0.150 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 84 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 86 | 0.150 |
Why?
|
| Conditioning, Operant | 1 | 2017 | 73 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2017 | 102 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2018 | 101 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 79 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 601 | 0.140 |
Why?
|
| Cell Death | 1 | 2017 | 267 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2017 | 168 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 190 | 0.140 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 119 | 0.140 |
Why?
|
| Molecular Structure | 1 | 2017 | 492 | 0.130 |
Why?
|
| Environmental Pollutants | 2 | 2015 | 179 | 0.130 |
Why?
|
| Curriculum | 1 | 2018 | 265 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.130 |
Why?
|
| Ileum | 1 | 2014 | 15 | 0.130 |
Why?
|
| Cell Biology | 1 | 2014 | 12 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 103 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 61 | 0.120 |
Why?
|
| Cecum | 3 | 2020 | 16 | 0.120 |
Why?
|
| Research | 1 | 2015 | 163 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 171 | 0.110 |
Why?
|
| Sensory Gating | 1 | 2012 | 6 | 0.100 |
Why?
|
| Parvalbumins | 1 | 2012 | 16 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1180 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2011 | 19 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2021 | 1518 | 0.100 |
Why?
|
| Interneurons | 1 | 2012 | 56 | 0.100 |
Why?
|
| Universities | 1 | 2015 | 442 | 0.100 |
Why?
|
| Selenoprotein P | 1 | 2012 | 50 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1568 | 0.100 |
Why?
|
| Aged | 1 | 2023 | 6741 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 166 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2011 | 141 | 0.100 |
Why?
|
| Hybrid Cells | 2 | 2001 | 20 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1039 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2011 | 83 | 0.100 |
Why?
|
| Ventral Tegmental Area | 1 | 2011 | 36 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 188 | 0.090 |
Why?
|
| Female | 5 | 2020 | 20969 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 408 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1398 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 502 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2010 | 87 | 0.090 |
Why?
|
| Acetylcholine | 2 | 2024 | 73 | 0.080 |
Why?
|
| Microdialysis | 1 | 2007 | 18 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2007 | 87 | 0.070 |
Why?
|
| Dihydro-beta-Erythroidine | 2 | 2011 | 4 | 0.070 |
Why?
|
| Magnesium | 1 | 2007 | 97 | 0.070 |
Why?
|
| Veratridine | 1 | 2006 | 1 | 0.070 |
Why?
|
| Quinpirole | 1 | 2006 | 16 | 0.070 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 30 | 0.070 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 44 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 63 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2006 | 67 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 550 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 289 | 0.060 |
Why?
|
| Hawaii | 3 | 2018 | 1929 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 513 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 133 | 0.050 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2002 | 5 | 0.050 |
Why?
|
| Acetates | 1 | 2002 | 21 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2002 | 34 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 56 | 0.050 |
Why?
|
| Amines | 1 | 2002 | 39 | 0.050 |
Why?
|
| Gene Expression | 2 | 2015 | 674 | 0.050 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 10 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 115 | 0.050 |
Why?
|
| Animal Experimentation | 1 | 2021 | 2 | 0.050 |
Why?
|
| Potassium Chloride | 1 | 2001 | 28 | 0.050 |
Why?
|
| Diet | 2 | 2020 | 801 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 46 | 0.050 |
Why?
|
| Bradykinin | 1 | 2000 | 22 | 0.050 |
Why?
|
| Triglycerides | 1 | 2021 | 138 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 52 | 0.050 |
Why?
|
| Caffeine | 1 | 2000 | 28 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2001 | 101 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2021 | 62 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 64 | 0.050 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 102 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2000 | 184 | 0.050 |
Why?
|
| Potassium | 1 | 2000 | 112 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2000 | 223 | 0.050 |
Why?
|
| Glioma | 1 | 2000 | 79 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2000 | 128 | 0.040 |
Why?
|
| Metabolome | 1 | 2020 | 53 | 0.040 |
Why?
|
| Kinetics | 1 | 2001 | 708 | 0.040 |
Why?
|
| Taurocholic Acid | 1 | 2018 | 7 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 21 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gossypol | 1 | 2018 | 5 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 339 | 0.040 |
Why?
|
| Seeds | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2018 | 32 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 282 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2019 | 124 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 859 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 139 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 93 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 68 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 61 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 928 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2001 | 587 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 137 | 0.040 |
Why?
|
| California | 1 | 2018 | 476 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2011 | 233 | 0.040 |
Why?
|
| Education, Medical | 1 | 2018 | 104 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 562 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 730 | 0.030 |
Why?
|
| Dioxins | 1 | 2015 | 8 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 434 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 80 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 27 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 67 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 66 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2015 | 127 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 540 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 80 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 230 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 352 | 0.020 |
Why?
|
| Aconitine | 1 | 2011 | 2 | 0.020 |
Why?
|
| GABA Agents | 1 | 2011 | 2 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 2011 | 7 | 0.020 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2011 | 6 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 19 | 0.020 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2011 | 12 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2011 | 33 | 0.020 |
Why?
|
| Conotoxins | 1 | 2011 | 18 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 343 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 972 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2002 | 136 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 2002 | 83 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 223 | 0.010 |
Why?
|